Pfizer to conduct trials of antiviral Covid-19 pill in Russia
Pfizer said earlier this month the experimental antiviral pill cut by 89% the chance of hospitalisation or death for adults at risk of severe disease
Pfizer said earlier this month the experimental antiviral pill cut by 89% the chance of hospitalisation or death for adults at risk of severe disease